Sign Up to like & get
recommendations!
0
Published in 2019 at "PLoS ONE"
DOI: 10.1371/journal.pone.0220711
Abstract: Nowadays CHK2 mutation is studied frequently in hereditary breast and ovarian cancer patients in addition to BRCA1/BRCA2. CHK2 is a tumor suppressor gene that encodes a serine/threonine kinase, also involved in pathways such as DNA…
read more here.
Keywords:
risk;
breast;
chk2 gene;
chk2 ... See more keywords